Money Follows the Person Rebalancing Grant Demonstration Program
Page 2

And in the process, the program also seeks to achieve the following objectives:

a) Increase the use of Home and Community Based Services (HCBS) and reduce the use of institutionally-based services;

b) Eliminate barriers and mechanisms in State law, State Medicaid plans, or State budgets that prevent or restrict the flexible use of Medicaid funds to enable Medicaid-eligible individuals to receive long-term care in the settings of their choice;

c) Strengthen the ability of Medicaid programs to assure continued provision of HCBS to those individuals who choose to transition from institutions;

d) Ensure that procedures are in their proper places to provide quality assurance and continuous quality
improvement of HCBS.

In order to support these initiatives, the Centers for Medicare & Medicaid Services is ready to administer funds in the amount of $1,700,000.

The CMS has stipulated that any State Medicaid Agency not currently participating in the MFP Rebalancing Demonstration may submit an application under the Money Follows the Person Rebalancing Grant Demonstration Program.

The United States Department of Health and Human Services, the mother agency funding the Money Follows the Person Rebalancing Grant Demonstration Program, is the country's leading agency that is responsible for protecting the health of all Americans through the provision of essential human services to everyone, especially to those who are vulnerable and medically challenged.

Money Follows the Person Rebalancing Grant Demonstration Program
  Back to Page 1

About The Author Michael Saunders is an editor of TopGovernmentGrants.com one the the most comprehensive Websites offering information on government grants and federal government programs. He also maintains Websites providing resources on environmental grants and grants for youth programs.

Additional Resources

category - Health Grants

Small Business Innovation Research Phase IIB Bridge Awards
In line with this mission, the NIH has recently constituted the Small Business Innovation Research Phase IIB Bridge Awards to Accelerate the Development of Cancer Therapeutics, Imaging Technologies, Interventional Devices, Diagnostics, and Prognostics Toward Commercialization Program.

---

2012 Tuberous Sclerosis Complex Clinical Trial Award Program
In line with this mission, the United States Department of Defense has recently established the 2012 Tuberous Sclerosis Complex Clinical Trial Award Program in an attempt to financially support the studies regarding the promotion innovative research focused on decreasing the clinical impact of tuberous sclerosis complex (TSC).

---

Eradication of HIV from CNS Reservoirs: Implications for Therapeutics Grant Program
The National Institutes of Health has collaborated with The National Institute of Mental Health (NIMH), The National Institute of Neurological Disorders and Stroke (NINDS), and The National Institute of Allergy and Infectious Disease (NIAID) in an attempt to establish the Eradication of HIV from CNS Reservoirs: Implications for Therapeutics Grant Program.

---

Development of Therapeutics and Diagnostics for Biodefense Program
The National Institutes of Health, in partnership with the National Institute of Allergy and Infectious Diseases(NIAID), has established the Development of Therapeutics and Diagnostics for Biodefense Program in an attempt to seek research proposals that desire to support the development of lead candidate diagnostics or therapeutics against NIAID Category A, B, or C priority agents.

---